SCHEMBL17540401

SCHEMBL17540401

NC(=O)c1cc(-c2cc(NC=O)c(F)c(C(N)=O)c2)cc(NC=O)c1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 2/20 0.33
IKBKB O14920 5/20 0.33
CHUK O15111 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAP2K2 P36507 1/20 0.33
MAP2K1 Q02750 1/20 0.33
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DGAT1 O75907 1/20 0.33
ROCK2 O75116 2/20 0.32
ERN1 O75460 2/20 0.32
MEN1 O00255 1/20 0.31
JAK2 O60674 1/20 0.31
EIF2AK2 P19525 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17540395 0.83 DGAT1 (0.41) KDM5AIKBKBKDM4EALDH1A1MAP2K2
SCHEMBL17540396 0.83 MAP2K2 (0.40) KDM5AKDM4EALDH1A1MAP2K2MAP2K1
SCHEMBL17540400 0.80 MAPT (0.43) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL16122342 0.77 DGAT1 (0.43) IKBKBCHUKKDM4EALDH1A1DGAT1
SCHEMBL17540384 0.76 KDM4E (0.44) KDM4EALDH1A1NPC1PKMRAB9A
SCHEMBL16640691 0.72 IKBKB (0.57) IKBKBCHUKKDM4EKMT2ARXFP1
SCHEMBL17540399 0.69 CA1 (0.34) KDM5AMEN1KMT2A
SCHEMBL2612359 0.67 KDM4E (0.58) KDM4EALDH1A1NPC1PKMRAB9A
SCHEMBL16639875 0.67 ERN1 (0.38) KDM5AKDM4EALDH1A1MAP2K1NPC1
SCHEMBL7806435 0.67 KDM5A (0.45) KDM5AKDM4EALDH1A1NPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170313650-A1 SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES UDC IRELAND LIMITED (IE) 2017-11-02 US disclosed
US-9718764-B2 Synthetic building blocks for the production of materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2017-08-01 US disclosed
US-20160046563-A1 SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES UDC IRELAND LIMITED (IE) 2016-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046563-A1 SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES TBCB, CYBA, BMP2 KDM5A 3063/4885IKBKB 4431/4885CHUK 4607/4885
US-20170313650-A1 SYNTHETIC BUILDING BLOCKS FOR THE PRODUCTION OF MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES TBCB, CYBA, BMP2 KDM5A 3063/4885IKBKB 4431/4885CHUK 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.